APA (7th ed.) Citation

Liu, X., Yan, Y., Yi, J., Luo, D., Geng, J., Huang, H., . . . Wang, H. (2025). Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn's disease: A real-world retrospective cohort study. BMC Gastroenterology, 25(1), 1. https://doi.org/10.1186/s12876-025-04323-x

Chicago Style (17th ed.) Citation

Liu, Xiaoyu, et al. "Ustekinumab Trough Concentrations Predict Clinical Remission in Perianal Fistulizing Crohn's Disease: A Real-world Retrospective Cohort Study." BMC Gastroenterology 25, no. 1 (2025): 1. https://doi.org/10.1186/s12876-025-04323-x.

MLA (9th ed.) Citation

Liu, Xiaoyu, et al. "Ustekinumab Trough Concentrations Predict Clinical Remission in Perianal Fistulizing Crohn's Disease: A Real-world Retrospective Cohort Study." BMC Gastroenterology, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12876-025-04323-x.